Novel methods and compositions for treatment of angiogenic diseases
US5086164A · kind A · utility
23Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 27, 1989 |
| Grant date | Feb 4, 1992 |
| Priority date | — |
| Expiry date | Dec 27, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The subject invention pertains to the use of recombinant PF4 (rPF4) as well as full length novel analogs (mutants) of rPF4, and peptide fragments thereof, to inhibit angiogenesis. rPF4, analogs, and certain fragments are shown to have utility for treating angiogenic diseases and for the inhibition of endothelial cell proliferation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.